Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion.
Lucianne C M LangezaalErik J R J van der HoevenFrancisco J A Mont'AlverneJoão J F de CarvalhoFabrício O LimaDiederik W J DippelAad van der LugtRob T H LoJelis BoitenGeert J Lycklama À NijeholtJulie StaalsWim H van ZwamPaul J NederkoornCharles B L M MajoieJohannes C GerberMikael MazighiMichel PiotinAndrea ZiniStefano ValloneJeannette HofmeijerSheila O MartinsChristian H NolteKristina SzaboFrancisco Antunes DiasDaniel G AbudMarieke J H WermerMichel J M RemmersHauke SchneiderChristina M RueckertKarlijn F de LaatAlbert J YooPieter-Jan van DoormaalAdriaan C G M van EsBart J EmmerPatrik MichelVolker PuetzHeinrich J AudebertOctavio M Pontes-NetoJan-Albert VosL Jaap KappelleAle AlgraWouter J Schonewillenull nullPublished in: The New England journal of medicine (2021)
Among patients with stroke from basilar-artery occlusion, endovascular therapy and medical therapy did not differ significantly with respect to a favorable functional outcome, but, as reflected by the wide confidence interval for the primary outcome, the results of this trial may not exclude a substantial benefit of endovascular therapy. Larger trials are needed to determine the efficacy and safety of endovascular therapy for basilar-artery occlusion. (Funded by the Dutch Heart Foundation and others; BASICS ClinicalTrials.gov number, NCT01717755; Netherlands Trial Register number, NL2500.).